首页> 外文会议>Congress ofthe International Pig Veterinary Society >EFFICACY OF Suvaxyn~R PCV2 VACCINE ON PCV-2 VIREMIA IN A PCVAD-AFFECTEDHERD IN THAILAND
【24h】

EFFICACY OF Suvaxyn~R PCV2 VACCINE ON PCV-2 VIREMIA IN A PCVAD-AFFECTEDHERD IN THAILAND

机译:Suvaxyn〜R PCV2疫苗在泰国PCVAD-Danksherd的PCV-2遗体疫苗疗效

获取原文

摘要

In Thailand, a retrospective study using immunohistochemistry on paraffin-embedded tissues (2000-20 02) revealed the prevalence of PCV2 infection about 38.76 % (50/129)( 1). These data indicated that Porcine Circovirus Associated diseases (PCVAD) is considerably of important for the Thai swine industry. Suvaxyn~R PCV2 (Fort Dodge Animal health, USA) is the Chimeric PCV1-2 vaccine containing immunogenic capsid gene cloned of PCV2 into the backbone of the nonpathogenic PCV1. Experimental vaccination with the chimeric PCV1-2 significantly reduced viremia and decreasing risk of clinical disease (2). The objective of this study is to investigate the efficacy of Suvaxyn PCV2 on PCV-2 viremic condition in a PCVAD-affected herd in Thailand.
机译:在泰国,在石蜡包埋组织(2000-20 02)上使用免疫组织化学的回顾性研究显示PCV2感染的患病率约为38.76%(50/129)(1)。这些数据表明,猪胃肠病毒相关疾病(PCVAD)对于泰国猪工业而言非常重要。 Suvaxyn〜R PCV2(德国堡垒动物健康,USA)是含有免疫原性衣壳基因的嵌合PCV1-2疫苗,其克隆到非致原PCV1的骨架中。实验疫苗接种嵌合PCV1-2显着降低了病毒血症和临床疾病风险降低(2)。本研究的目的是探讨Suvaxyn PCV2在泰国PCVAD受影响的群体中PCV-2雌激酶病症的疗效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号